XBiotech, Inc. (XBIT)
1.91
-0.06
(-3.05%)
USD |
NASDAQ |
Oct 23, 16:00
1.91
0.00 (0.00%)
After-Hours: 18:34
XBiotech Price to Book Value : 0.4533 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 0.4675 |
| October 21, 2026 | 0.4723 |
| October 20, 2026 | 0.4794 |
| October 19, 2026 | 0.4747 |
| October 16, 2026 | 0.5031 |
| October 15, 2026 | 0.5126 |
| October 14, 2026 | 0.5126 |
| October 13, 2026 | 0.5126 |
| October 12, 2026 | 0.5435 |
| October 09, 2026 | 0.5435 |
| October 08, 2026 | 0.5221 |
| October 07, 2026 | 0.5198 |
| October 06, 2026 | 0.5126 |
| October 05, 2026 | 0.5174 |
| October 02, 2026 | 0.5198 |
| October 01, 2026 | 0.5221 |
| September 30, 2026 | 0.5198 |
| September 29, 2026 | 0.5174 |
| September 28, 2026 | 0.5103 |
| September 25, 2026 | 0.515 |
| September 24, 2026 | 0.5126 |
| September 23, 2026 | 0.5174 |
| September 22, 2026 | 0.5174 |
| September 21, 2026 | 0.5174 |
| September 18, 2026 | 0.5198 |
| Date | Value |
|---|---|
| September 17, 2026 | 0.5174 |
| September 16, 2026 | 0.5103 |
| September 15, 2026 | 0.5209 |
| September 14, 2026 | 0.515 |
| September 11, 2026 | 0.5198 |
| September 10, 2026 | 0.515 |
| September 09, 2026 | 0.5174 |
| September 08, 2026 | 0.5174 |
| September 04, 2026 | 0.5221 |
| September 03, 2026 | 0.5221 |
| September 02, 2026 | 0.5198 |
| September 01, 2026 | 0.5269 |
| August 31, 2026 | 0.5459 |
| August 28, 2026 | 0.5387 |
| August 27, 2026 | 0.5459 |
| August 26, 2026 | 0.5482 |
| August 25, 2026 | 0.5459 |
| August 24, 2026 | 0.5482 |
| August 21, 2026 | 0.5411 |
| August 20, 2026 | 0.5482 |
| August 19, 2026 | 0.5482 |
| August 18, 2026 | 0.5387 |
| August 17, 2026 | 0.5482 |
| August 14, 2026 | 0.5459 |
| August 13, 2026 | 0.553 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.598 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.019 |
| Vericel Corp. | 5.884 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0214 |
| Price | 1.91 |
| Earnings Yield | -77.51% |
| Market Cap | 58.23M |
| PEGY Ratio | -0.0214 |